Cardiovascular Systems Inc. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
35,290.00
32,822.00
56,024.00
1,792.00
1,712.00
Depreciation, Depletion & Amortization
1,367.00
2,321.00
3,917.00
4,135.00
3,934.00
Other Funds
3,371.00
2,882.00
-
4.00
14.00
Funds from Operations
22,013.00
14,498.00
38,067.00
14,191.00
16,236.00
Changes in Working Capital
4,825.00
7,859.00
14,484.00
5,397.00
6,562.00
Net Operating Cash Flow
26,838.00
22,357.00
23,583.00
19,588.00
9,674.00
Capital Expenditures
13,419.00
21,280.00
4,631.00
1,825.00
3,069.00
Purchase/Sale of Investments
-
1,747.00
1,212.00
46.00
2,344.00
Net Investing Cash Flow
13,419.00
23,027.00
3,769.00
1,779.00
5,095.00
Issuance/Reduction of Debt, Net
5,050.00
2,400.00
-
20,944.00
-
Net Financing Cash Flow
98,952.00
2,634.00
4,148.00
29,465.00
3,769.00
Net Change in Cash
58,695.00
42,750.00
23,204.00
47,274.00
8,348.00
Free Cash Flow
39,555.00
42,682.00
27,401.00
18,607.00
7,718.00
Other Sources
-
-
-
-
318.00
Change in Capital Stock
100,631.00
2,152.00
4,148.00
8,517.00
3,755.00
Other Uses
-
-
350.00
-
-

About Cardiovascular Systems

View Profile
Address
1225 Old Highway 8 Northwest
St. Paul Minnesota 55112
United States
Employees -
Website http://www.csi360.com
Updated 07/08/2019
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. Its products are primarily catheter-based platforms capable of treating a range of vessel sizes and plaque types.